In December 2017 the International Association of Athletics Federations (IAAF) has reported an anti-doping rule violation against the Moroccan Athlete Mousaab Hadout after his sample tested positive for the prohibited substance Recombinant Erythropoietin (rhEPO). After notification a provisional suspension was ordered.
The Athlete signed the Athletics Integrity Unit Form in which he admitted the violation, waived his right to be heard and accepted the sanction proposed by the IAAF. He explained that he had used Actoveging prior to the competition in order to treat muscle soreness.
Accordingly the IAAF decides on 18 July 2018 to impose a 4 year period of ineligibility on the Athlete starting on 29 June 2018.
